Description
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 778 of the ATP7B protein (p.Arg778Gln). This variant is present in population databases (rs28942074, gnomAD 0.03%). This missense change has been observed in individual(s) with Wilson disease (PMID: 11405812, 20931554, 21796144, 27022412). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 550914). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP7B protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ATP7B function (PMID: 9837819). This variant disrupts the p.Arg778 amino acid residue in ATP7B. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10453196, 11243728, 11405812, 11479773, 16998622, 17160357, 20517649, 21682854, 23333878, 23518715, 25086856, 25988284, 27398169, 28212618). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |